1.7K
Publications
145.7K
Citations
170
Authors
Nuremberg
Germany
Novartis (Germany) is a company institution in Nuremberg, Germany known for medicine, immunology, and oncology.
1.7K
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Andreas Hochhaus, Sebastian Kreil, A. Corbin et al. · Leukemia · 2002 · 900 citations
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz, Klemens Budde, Marwan Mannaa et al. · New England Journal of Medicine · 2010 · 571 citations · Full text
Rows per page
1–5 of 1.7K
170
| Publications | Citations | H-Index | |
|---|---|---|---|
MB Novartis (Germany) | 132 | 3.8K | 38 |
MB Novartis (Germany) | 85 | 6K | 36 |
HG Novartis (Germany) | 62 | 5.7K | 35 |
GW Novartis (Germany) | 109 | 3.7K | 35 |
AB Novartis (Germany) | 78 | 2.6K | 29 |
Rows per page
1–5 of 170